Sequential catalytic nanomedicinal utilization for synergistic drug delivery application in cancer nanotechnology

Cancer is the major cause of the increase in the deah rate globally, with an escalating number of cases every year. However, early detection of cancer and its treatment have remained a key challenge. The rapid advancement of nanotechnology toward nanomedicine holds considerable potential for improving cancer therapy techniques. The concept of "nanocatalytic medicine" has emerged due to the rapid proliferation of scientific investigations concerning the biomedical applications of nanocatalysts, which are anticipated to advance the field. This emerging catalytic therapeutic approach is expected to have a bigger impact on the discipline of nanomedicine. The goal of introducing drug delivery systems is to enhance the therapeutic effect or reduce drug toxicity. This manuscript explores an in-depth analysis of the rationale for developing nanomedicine products for cancer therapy. In addition, numerous techniques for the delivery of drugs to tumor cells have been introduced. Following this, catalytic-based nanomedicine employs a diverse array of nanoparticles, which has the potential to be extraordinarily beneficial in the treatment of cancer. This article offers a succinct synopsis of recent advancements in co-delivery agents and nanocarriers, including the characterization of nanocarriers and the successful implementations of drug-delivery cases in synergistic systems.